Cytokinetics: Q1 Earnings Insights

Cytokinetics: Q1 Earnings Insights

Cytokinetics CYTK reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Cytokinetics missed estimated earnings by 8.51%, reporting an EPS of $-1.02 versus an estimate of $-0.94.

Revenue was down $5.40 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.48 which was followed by a 3.15% increase in the share price the next day.

Here's a look at Cytokinetics's past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.84 -0.76 -0.65 -0.58
EPS Actual -0.36 -0.95 -0.86 -0.66
Revenue Estimate 6.20M 6.42M 5.45M 6.58M
Revenue Actual 55.60M 5.44M 2.84M 6.55M

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.84 -0.76 -0.65 -0.58
EPS Actual -0.36 -0.95 -0.86 -0.66
Revenue Estimate 6.20M 6.42M 5.45M 6.58M
Revenue Actual 55.60M 5.44M 2.84M 6.55M

To track all earnings releases for Cytokinetics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarnings